Paclitaxel-Loaded PLGA/Au Nanocylinders for the Photothermal-Chemotherapy Treatment of Cancer
Source abstract
Abstract
UV-nanoimprint lithography (UV-NIL) has been proved to be an efficient method for preparing nanodrug delivery systems. Herein, we used UV-NIL associated with the glancing angle deposition (GLAD) process of electron beam evaporation to prepare Au-coated PLGA nanocylinders loaded with PTX (PTX-PLGA-Au NCs) to enhance anticancer efficacy by the cooperative treatment of photothermal-chemotherapy. PTX-PLGA-Au NCs with different length-to-diameter ratios can be prepared by controlling the concentration of PLGA and regulating the angle of GLAD. Upon 808 nm near-infrared (NIR) irradiation, PTX-PLGA-Au NCs exhibit a stable and repeatable photothermal effect. Besides, hyperthermia generated by the Au layer on the surface of PTX-PLGA-Au NCs under laser irradiation promoted the rapid release of PTX. The in vitro studies demonstrated that PTX-PLGA-Au NCs can achieve the synergistic effect of photothermal-chemotherapy, leading to increased cell cytotoxicity. Therefore, UV-NIL combined with the GLAD process produced a promising nanofabrication method for efficiently developing a multifunctional nanoplatform for cancer treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Biological and Chemical Engineering, Nanyang Institute of Technology, Nanyang 473000, China
National Laboratory of Solid State Microstructures, College of Engineering and Applied Sciences, Nanjing University, Nanjing 210093, China
Funding
Nanyang Institute of Technology · Key Scientific Research Projects in Colleges and Universities of Henan Province · Henan Science and Technology Public Relations Project
References (54)
Show source-provided references
1. 10.1016/j.actbio.2020.02.01310.1016/j.actbio.2020.02.013 ↗
2. 10.1080/10717544.2017.138845210.1080/10717544.2017.1388452 ↗
3. 10.1016/j.jddst.2023.10465210.1016/j.jddst.2023.104652 ↗
4. 10.1039/d1tb01771c10.1039/d1tb01771c ↗
5. 10.1080/10717544.2020.185622310.1080/10717544.2020.1856223 ↗
6. 10.1016/j.jddst.2021.10249110.1016/j.jddst.2021.102491 ↗
7. 10.3389/fbioe.2021.79888210.3389/fbioe.2021.798882 ↗
8. 10.1007/s12272-020-01206-510.1007/s12272-020-01206-5 ↗
9. 10.1021/acsami.5b0085810.1021/acsami.5b00858 ↗
10. 10.1186/s12951-021-01011-210.1186/s12951-021-01011-2 ↗
11. 10.1021/acsami.7b1732310.1021/acsami.7b17323 ↗
12. 10.1039/D1CS01148K10.1039/D1CS01148K ↗
13. 10.3390/molecules2806255310.3390/molecules28062553 ↗
14. 10.1021/acsami.1c0486810.1021/acsami.1c04868 ↗
15. 10.1016/j.ccr.2020.21354810.1016/j.ccr.2020.213548 ↗
16. 10.1002/anie.20210783610.1002/anie.202107836 ↗
17. 10.1021/am500715f10.1021/am500715f ↗
18. 10.1016/j.cej.2020.12449410.1016/j.cej.2020.124494 ↗
19. 10.1021/acsami.3c1316510.1021/acsami.3c13165 ↗
20. 10.2147/IJN.S23244910.2147/IJN.S232449 ↗
21. 10.1016/j.biomaterials.2018.06.03910.1016/j.biomaterials.2018.06.039 ↗
22. 10.1016/j.cej.2019.12259910.1016/j.cej.2019.122599 ↗
23. 10.1016/j.snb.2017.12.04810.1016/j.snb.2017.12.048 ↗
24. 10.3389/fbioe.2020.0099010.3389/fbioe.2020.00990 ↗
25. 10.1016/j.talanta.2019.03.05710.1016/j.talanta.2019.03.057 ↗
26. 10.1021/acsbiomaterials.2c0153910.1021/acsbiomaterials.2c01539 ↗
27. 10.1002/adma.20160171010.1002/adma.201601710 ↗
28. 10.1073/pnas.121689311010.1073/pnas.1216893110 ↗
29. 10.1073/pnas.130834511010.1073/pnas.1308345110 ↗
30. 10.1038/srep2456710.1038/srep24567 ↗
31. 10.1002/anie.20110444910.1002/anie.201104449 ↗
32. 10.1038/nmat379210.1038/nmat3792 ↗
33. 10.1002/smll.20160280910.1002/smll.201602809 ↗
34. 10.1016/j.biomaterials.2014.04.04310.1016/j.biomaterials.2014.04.043 ↗
35. 10.1016/j.biomaterials.2010.06.05110.1016/j.biomaterials.2010.06.051 ↗
36. 10.1016/j.jconrel.2015.11.01610.1016/j.jconrel.2015.11.016 ↗
37. 10.1016/j.jconrel.2021.04.00510.1016/j.jconrel.2021.04.005 ↗
38. 10.1016/j.jiec.2018.09.05110.1016/j.jiec.2018.09.051 ↗
39. 10.1021/nn301215q10.1021/nn301215q ↗
40. 10.1002/anie.20120914510.1002/anie.201209145 ↗
41. 10.1021/nl104117p10.1021/nl104117p ↗
42. 10.1021/acs.nanolett.6b0397110.1021/acs.nanolett.6b03971 ↗
43. 10.1021/nl404655810.1021/nl4046558 ↗
44. 10.1016/j.addr.2018.07.00610.1016/j.addr.2018.07.006 ↗
45. 10.1021/acsami.9b2134610.1021/acsami.9b21346 ↗
46. 10.1016/j.solener.2022.02.05710.1016/j.solener.2022.02.057 ↗
47. 10.1002/adfm.20200422710.1002/adfm.202004227 ↗
48. 10.1002/admi.20230085610.1002/admi.202300856 ↗
49. 10.1016/j.actbio.2019.01.02610.1016/j.actbio.2019.01.026 ↗
50. 10.1016/j.nantod.2017.06.01010.1016/j.nantod.2017.06.010 ↗
51. 10.1016/j.ccr.2019.21304110.1016/j.ccr.2019.213041 ↗
52. 10.3390/mi1407139010.3390/mi14071390 ↗
53. 10.1016/j.ijpharm.2013.06.01210.1016/j.ijpharm.2013.06.012 ↗
54. 10.1016/j.ijpharm.2011.05.04910.1016/j.ijpharm.2011.05.049 ↗